Medications for Squamous Cell Carcinoma Of The Head And Neck

4 results
  • erbitux - cetuximab solution

    (Cetuximab)
    Imclone Llc
    Erbitux treats locally or regionally advanced and recurrent or metastatic squamous cell carcinoma of the head and neck, and K-Ras wild-type, EGFR-expressing metastatic colorectal cancer. Also indicated for BRAF V600E mutation-positive metastatic colorectal cancer with encorafenib after prior therapy.
  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    Keytruda is a PD-1-blocking immunotherapy indicated for numerous cancers including melanoma, non-small cell lung cancer, head and neck cancer, bladder cancer, colorectal cancer, gastric cancer, cervical cancer, renal cell carcinoma, endometrial carcinoma, triple-negative breast cancer, and other solid tumors.
  • opdivo - nivolumab injection

    (Nivolumab)
    E.R. Squibb & Sons, L.L.C.
    Opdivo is a PD-1 blocking antibody indicated for multiple cancers including melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, esophageal cancer, and gastric cancers in adults and select pediatric patients.